# Benzonatate

NDC: 72789-232
Generic name: Benzonatate
Labeler / Manufacturer: PD-Rx Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20181221

FDA application: ANDA206948

## Active ingredients

- BENZONATATE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72789-232"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72789-232
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a5460bf-5242-4726-9dfa-e215529842c3